Defense World
14 Mar 2026, 05:30 UTC · 30w ago
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Expands By 137.6%
Impact · against what's priced in
The increase in short interest for ADXN is statistically negligible and does not alter the company's fundamental outlook. With only 1.1% of shares sold short, the bearish sentiment is too small to create a price catalyst or a significant systemic risk.
- ADXN−0.10
No priced-in read yet
- In context
Short interest grew by 137.6% to 11,951 shares, but the absolute short interest remains very low at 1.1% of the company's stock.
Read from the article alone
Search tags
